Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01382316 · ClinicalTrials.gov registry record · Phase 3
Making Alcoholics Anonymous Easier
A Phase 3 study of Alcohol Dependence and Drug Dependence, sponsored by Alcohol Research Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 508
- Enrollment target
- 1
- Study location
NCT01382316: Completed Phase 3 study of Alcohol Dependence and Drug Dependence, sponsored by Alcohol Research Group.
NCT01382316 is a Phase 3 study of Alcohol Dependence and Drug Dependence that has completed, run by Alcohol Research Group. The registered enrollment target is 508 participants, above the 302-participant average among 43 other Alcohol Dependence trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01382316, a Phase 3 study of Alcohol Dependence and Drug Dependence, has completed, sponsored by Alcohol Research Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 508 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests the effectiveness of Making Alcoholics Anonymous Easier (MAAEZ), a manual-guided intervention designed to help alcohol and drug dependent clients connect with individuals encountered in AA. An OFF/ON design was used (n=508). MAAEZ effectiveness was determined by comparing abstinence rates of participants recruited during ON (MAAEZ intervention) and OFF (usual care) conditions and by studying the effect of the number of MAAEZ sessions attended. Better outcomes were hypothesized for MAAEZ vs. usual care. At 12 months, more clients in the ON condition (vs. OFF) reported past 30-day abstinence from alcohol, drugs, and both alcohol and drugs. Abstinence increased for each additional MAAEZ session received. MAAEZ appeared especially effective for those with more prior AA exposure, severe psychiatric problems, and atheists/agnostics. Mechanisms of action for MAAEZ (mediators of the MAAEZ effect) include: doing service in AA/NA/CA; having a sponsor; having a social network supportive of abstinence; and comfort being in meetings. MAAEZ represents an evidence-based intervention that is easily implemented in existing treatment programs.
Primary Outcome
No alcohol and no drug consumed during the 30 days prior to 12-month follow-up interview
Conditions Studied
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Making Alcoholics Anonymous Easier (MAAEZ)
Study Locations (1)
California
- Alcohol Research Group - Emeryville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 508 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-08 |
| Phase | Phase 3 |
What the finished NCT01382316 record still lists
NCT01382316 is an interventional study that assigns participants to a tested intervention. The registered 508 participants enrollment target is mid-sized for trials with a published cap, above the 302-participant average among 43 other Alcohol Dependence trials with a reported enrollment target (68% higher).
The record links to 2 conditions, with Alcohol Dependence appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT01382316 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01382316 about?
NCT01382316 is a clinical study titled "Making Alcoholics Anonymous Easier". This study tests the effectiveness of Making Alcoholics Anonymous Easier (MAAEZ), a manual-guided intervention designed to help alcohol and drug dependent clients connect with individuals encountered in AA. An OFF/ON design was used (n=508). MAAEZ effectiveness was determined by comparing abstinence...
What is the current status of trial NCT01382316?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 508 participants. The study started on 2005-07. Estimated completion is 2007-08.
What conditions does trial NCT01382316 study?
This clinical trial studies the following conditions: Alcohol Dependence, Drug Dependence.
What interventions are being tested in trial NCT01382316?
The interventions under investigation include: Usual care (BEHAVIORAL), Making Alcoholics Anonymous Easier (MAAEZ) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01382316?
This trial is sponsored by Alcohol Research Group, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01382316 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01382316's enrollment target sits among peer trials
508 3rd of 43 higher than 41 of 43 other Alcohol Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).
COMPLETED · Phase 3
-
Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence
COMPLETED · Phase 3
-
The Impact of Heavy Alcohol Use on Saliva and Oral Health
RECRUITING
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
RECRUITING
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02115295 · 508 participants · Phase 2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
- NCT04692675 · 508 participants · NA
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
- NCT07391657 · 508 participants · Phase 3
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- NCT07484217 · 508 participants · Phase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia